Trial Holdings Inc.

141A

JP3635490000

Discount Stores

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
2,709 ^JPY	+2.73%		+6.03%	0.00%

05:40pm	EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug	MT
04:57pm	Biodexa Pharmaceuticals Gets Exclusive License for Phase 3 Ready Drug to Treat Familial Adenomatous Polyposis -- Shares Jump	MT

Trial Holdings Inc. has filed an IPO.

March 08, 2023 at 12:00 am EST

Trial Holdings Inc. has filed an IPO.

Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 25,655,600

Transaction Features: Sponsor Backed Offering

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	TRIAL HOLDINGS INC.	2,709 JPY	+2.73%	+6.03%	2.01B
	NOMURA HOLDINGS, INC.	914.2 JPY	+1.56%	+0.87%	17.2B

Latest news about Trial Holdings Inc.

EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug	11:40am	MT
Biodexa Pharmaceuticals Gets Exclusive License for Phase 3 Ready Drug to Treat Familial Adenomatous Polyposis -- Shares Jump	10:57am	MT
Allogene Therapeutics Gets $15 Million Grant from California Institute for Regenerative Medicine for Cancer Drug Development	10:40am	MT
Bristol-Myers Squibb Says European Regulator Recommends Approval of Bladder Cancer Combination Therapy	09:42am	MT
Romanian court says internet personality Tate's human trafficking trial can start	09:18am	RE
Proteome Sciences Wins GBP500,000 Spectrometry Services Contract in US	06:39am	MT
Proteome wins GBP500,000 deal to supply mass spectrometry services	06:20am	AN
Former tabloid publisher to face more questions in Trump hush-money trial	06:09am	RE
AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract	05:42am	AN
Thoma Bravo snaps up Darktrace for USD5 billion	04:16am	AN
CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication	02:05am	MT
Idorsia Gets EU Medicines Regulator's Positive Opinion for Resistant Hypertension Treatment	01:57am	MT
Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3%	01:16am	MT
Lykos Metals Uncovers Chargeability Anomalies at Erak Gold Prospect in Bosnia-Herzegovina	11:53pm	MT
Suvo Strategic Minerals Completes Trial Pours for Geopolymer Concrete; Shares Up 8%	09:13pm	MT
Trump compares campus Israel protests to 2017 white nationalist rally	08:12pm	RE
Trump trial hears new details on alleged 'catch and kill'	08:03pm	RE
Detained official held by Azerbaijan ends hunger strike, family says	Apr. 25	RE
FTSE 100 shakes off red-hot US inflation gauge	Apr. 25	AN
AbbVie Says Rinvoq Shows Superiority Versus Dupixent in Atopic Dermatitis Trial Primary Endpoint	Apr. 25	MT
Cordel rises on deal with national railway in APAC region	Apr. 25	AN
North American Morning Briefing : More Tech Earnings in Focus With GDP Data Adding to the Uncertainty	Apr. 25	DJ
Hush money testimony expected to focus on payment to ex-Playboy model	Apr. 25	RE
AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract	Apr. 25	AN
Abbisko Cayman's Liver Cancer Drug Gets US FDA Orphan Drug Designation	Apr. 25	MT

Trial Holdings Inc is a Japan-based holding company mainly engaged in the distribution and retail business and retail artificial intelligence (AI) business through its subsidiaries. The Company operates through two business segments. The Distribution and Retail segment mainly operates discount stores under the Trial brand that mainly provide daily necessities, home appliances, apparel goods, hobby goods, among others. Store formats include mega center, supercenter (SuC), smart and small store. The Retail Artificial Intelligence (AI) segment mainly provides products and solutions to retailers and food and consumer goods manufacturers that help improve customers' shopping experiences, physical store operations, and the efficiency of advertising and sales promotion activities. The Company also engages in resort-related businesses such as inn facilities and golf course management, as well as construction and real estate management business.

Sector

Discount Stores

Calendar

2024-05-13 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2,709 JPY

Average target price

3,200 JPY

Spread / Average Target

+18.12%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Discount Stores

	1st Jan change	Capi.
TRIAL HOLDINGS INC.	0.00%	2.01B
COSTCO WHOLESALE CORPORATION	+10.58%	320B
TARGET CORPORATION	+15.55%	75.92B
WAL-MART DE MÉXICO, S.A.B. DE C.V.	-5.60%	66.65B
DOLLAR GENERAL CORPORATION	+4.46%	31.34B
DOLLARAMA INC.	+21.09%	23.8B
PAN PACIFIC INTERNATIONAL HOLDINGS CORPORATION	+10.91%	14.28B
BJ'S WHOLESALE CLUB HOLDINGS, INC.	+14.87%	10.16B
SIAM MAKRO	+17.59%	9.22B
B&M EUROPEAN VALUE RETAIL S.A.	-5.78%	6.49B

Other Discount Stores